Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
Condition(s):Kidney CancerLast Updated:October 3, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:October 3, 2023Active, not recruiting
Condition(s):Blood Loss After a Total Hip ReplacementLast Updated:January 9, 2018Completed
Condition(s):Blood LossLast Updated:June 7, 2012Terminated
Condition(s):Blood TransfusionLast Updated:April 8, 2013Completed
Condition(s):HemostasisLast Updated:February 22, 2012Terminated
Condition(s):Blood Loss; Anatomic Total Shoulder Arthroplasty; Reverse Total Shoulder Arthroplasty; Transfusion; Tranexamic AcidLast Updated:November 2, 2021Completed
Condition(s):Postoperative AnemiaLast Updated:October 12, 2015Completed
Condition(s):Thromboses, Deep Vein; Tranexamic Acid Adverse ReactionLast Updated:February 12, 2019Unknown status
Condition(s):HemorrhageLast Updated:September 18, 2018Completed
Condition(s):Homeostasis; Cardiac SurgeryLast Updated:November 30, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.